Literature DB >> 18662627

Fast-track anesthesia with remifentanil and spinal analgesia for cardiac surgery: the effect on pain control and quality of recovery.

Pierre Lena1, Norbert Balarac, Diane Lena, Arnaud De La Chapelle, Jean-Jacques Arnulf, Alain Mihoubi, Michel Tapia, Francis Bonnet.   

Abstract

OBJECTIVES: To assess pain intensity and quality of postoperative recovery in patients given fast-track anesthesia and spinal analgesia versus patients treated with standard anesthesia.
DESIGN: A prospective, randomized, controlled study.
SETTING: A private institution. PARTICIPANTS: Eighty-three patients who underwent cardiac surgery with cardiopulmonary bypass were analyzed.
INTERVENTIONS: General anesthesia consisted of remifentanil and spinal analgesia (low-dose morphine and clonidine) for the fast-track group (FTG) and sufentanil without spinal analgesia for the control group (CG). During the postoperative period, paracetamol and patient-controlled intravenous analgesia (PCA) with morphine were given.
MEASUREMENTS AND MAIN RESULTS: Postoperative pain intensity was evaluated during 48 hours with visual analog scale scores and intravenous morphine consumption. Pain impact on quality of life was assessed with the brief pain inventory (BPI) score (days 1-8), and recovery was evaluated with the quality of recovery score (QoR-40, day 4). Compared with the CG, FTG pain intensity was significantly lower 0 to 4 (p < 0.01) and 6 to 12 hours (p < 0.05) after surgery, as was their cumulative intravenous PCA morphine consumption (p = 0.01). BPI scores supported that FTG patients had significantly (p < 0.01) less "pain at its worst" on days 1 and 2, their BPI-assessed pain interfered significantly less with daily life on day 1 (p < 0.001), and their global QoR-40 score (day 4) was significantly higher (p < 0.05).
CONCLUSIONS: Fast-track anesthesia combined with morphine-clonidine spinal analgesia controlled postoperative pain better and obtained a better QoR than conventional analgesia.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18662627     DOI: 10.1053/j.jvca.2008.04.012

Source DB:  PubMed          Journal:  J Cardiothorac Vasc Anesth        ISSN: 1053-0770            Impact factor:   2.628


  6 in total

1.  Use of quality of recovery score (QoR40) in the assessment of postoperative recovery and evaluation of enhanced recovery after surgery protocols.

Authors:  Yuu Tanaka; Atushi Yoshimura; Kyoko Tagawa; Dai Shida; Masahiko Kawaguchi
Journal:  J Anesth       Date:  2014-01-11       Impact factor: 2.078

Review 2.  Fast-track cardiac care for adult cardiac surgical patients.

Authors:  Wai-Tat Wong; Veronica Kw Lai; Yee Eot Chee; Anna Lee
Journal:  Cochrane Database Syst Rev       Date:  2016-09-12

3.  Newer isn't always better: comparative effectiveness of sevoflurane and isoflurane in cardiac surgery.

Authors:  Michael R Mathis; Sachin Kheterpal
Journal:  Can J Anaesth       Date:  2016-07-28       Impact factor: 6.713

4.  Perioperative Pain Management With Bilateral Pecto-intercostal Fascial Block in Pediatric Patients Undergoing Open Cardiac Surgery.

Authors:  Yang Zhang; Jia Min; Shibiao Chen
Journal:  Front Cardiovasc Med       Date:  2022-06-22

5.  Effects of bilateral Pecto-intercostal Fascial Block for perioperative pain management in patients undergoing open cardiac surgery: a prospective randomized study.

Authors:  Yang Zhang; Haixia Gong; Biming Zhan; Shibiao Chen
Journal:  BMC Anesthesiol       Date:  2021-06-22       Impact factor: 2.376

6.  Comparison of the effectiveness of low pressure pneumoperitoneum with profound muscle relaxation during laparoscopic donor nephrectomy to optimize the quality of recovery during the early post-operative phase: study protocol for a randomized controlled clinical trial.

Authors:  Denise M D Özdemir-van Brunschot; Gert J Scheffer; Albert Dahan; Janneke E E A Mulder; Simone A A Willems; Luuk B Hilbrands; Frank C H d'Ancona; Rogier A R T Donders; Kees J H M van Laarhoven; Michiel C Warlé
Journal:  Trials       Date:  2015-08-12       Impact factor: 2.279

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.